Care of patients in the severe stage of dementia

Clinical Diagnosis and Management of Alzheimer’s Disease, Third Edition

Volumn , Issue , 2006, Pages 233-246

  Sandman, Per Olof ^a   Edvardsson, David ^a   Winblad, Bengt ^b  

^a UMEÅ UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 40749096312     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.3109/9780203931714-22     Document Type: Chapter

References (55)

1. Sandman PO, Adolfsson R, Norberg A, Nyström L, Winblad B. Long-term care of the elderly. A descriptive study of 3600 patients living in different institutions in the county of Västerboten, Sweden. Compr Gerontol 1988; 2:120-133.
2. Graneheim UH. The meaning of interaction between persons with dementia and disturbing behaviour and their care providers [in Swedish. Umeå University Medical Dissertations, New Series No 906, Umeå, Sweden 2004.
3. Jansson L, Norberg A, Sandman PO, Athlin E, Asplund K. Interpreting facial expressions in patients in the terminal stage of the Alzheimer disease. OMEGA 1993; 26:309-324.
4. Athlin E, Norberg A, Asplund K. Caregivers’ perceptions and interpretations of severely demented patients during feeding in a task assignment system. Scand J Caring Sci 1990; 4:147-156.
5. Normann HK. Lucidity in people with severe dementia as a consequence of person-centered care. Umeå University Medical Dissertations, New series no 753, Department of Advanced Nursing.
6. Zingmark K, Norberg A, Sandman PO. Experience of athomeness and homesickness in patients with Alzheimer’s disease. Am J Alzheimer’s Care Relat Disord Res 1993; 8: 10-16.
7. Zingmark K, Sandman PO, Norberg A. Promoting a good life among people with Alzheimer’s disease. J Adv Nurs 2002; 38:50-58.
8. Edberg A-K. The nurse-patient encounter and the patient’s state. Effects of individual care and clinical group supervision in dementia care. Medical dissertation, The Medical Faculty, Lund University, Sweden. Bulletin No 2 from the Center of Caring Sciences and Department of Clinical Neuroscience.
9. Finkel SI, Costa e Silva J, Cohen G, Miller S, Sartorius N. Behavioral and psychological signs and symptoms of dementia: a consensus statement on current knowledge and implications for research and treatment. Int Psychogeriatr 1996; 8(suppl 3):497-500.
10. Reisberg B, Oppenheim G. Alzheimer’s disease - clinical course: methodologic implications for pharmacologic trials. Int Psychogeriatr 1992; 1:5-7.
11. Purundare N, Allen NPH, Burns A. Behavioural and psychological symptoms of dementia. Rev Clin Gerontol 2000; 10:245-260.
12. Grossberg GT, Desai AK. Management of Alzheimer’s disease. J Gerontol Series A Biol Sci Med Sci 2003; 58:331-353.
13. Bains J, Birks JS, Dening TD. Antidepressants for treating depression in dementia. Cochrane Database of Systematic Reviews 2002; Issue 4: CD003944. DOI: 10.1002/14651858. CD003944.
14. Homma A. Parameters considered in multinational clinical drug trials. Int Psychogeriatr 1996; 8:165-167.
15. Karlsson S, Bucht G, Eriksson S, Sandman PO. Factors relating to the use of physical restraints in geriatric care settings. J Am Geriatr Soc 2001; 49:1722-1728.
16. Norberg KG, Hellzén O, Sandman PO, Asplund K. The relationship between organizational climate and the content of daily life for people with dementia living in a groupdwelling. J Clin Nurs 2002; 11:137-146.
17. Wimo A, Gustafsson L, Mattson B. Predictive validity of factors influencing the institutionalization of elderly people with psycho-geriatric disorders. Scand J Prim Health Care 1992; 10:185-191.
18. Clyburn LD, Stones MJ, Hadjistavropoulos T, Tuokko H. Predicting caregiver burden and depression in Alzheimer’s disease. J Gerontol Series B Psychol Sci Social Sci 2000; 55: 2-13.
19. Norberg A. Ethics in the care of the elderly with dementia. In: Gillion R, ed. Principles of Health Care Ethics, Chichester: Wiley, 1994 721-731.
20. Hallberg IR, Norberg A. Nurses’ experiences of strain and their reactions in the care of severely demented patients. Int J Geriatr Psychiatry 1995; 10:757-766.
21. Miller BL, Darby A, Benson DF, Cummings JL, Miller MH. Aggressive, socially disruptive and antisocial behaviour associated with fronto-temporal dementia. Br J Psychiatry 1997; 170:150-155.
22. Holst G, Hallberg IR, Gustafson L. The relationship of vocally disruptive behaviour and previous personality in severely demented institutionalized patients. Arch Psychiatr Nurs 1997; 11:147-154.
23. Eriksson S, Minthon L, Moksnes KM, et al. and the BPSD reference group. BPSD from a Nordic Perspective. Behavioural and Psychological symptoms in Dementia. A State-of-the-Art Document. Västra Frölunda, Sweden: Janssen Cilag AB 2000.
24. Robinson P, Giorgi B, Wahlund LO, Ekman SL. The experience of early dementia: a three-year longitudinal phenomenological case study in younger persons with suspected and early stage dementia: their experiences, concerns and need for support. Licentiate thesis, Department of Clinical Neuroscience, Occupational Therapy and Elderly Care Research, Division of Geriatric Medicine, Karolinska Institutet, Stockholm, Sweden.
25. Graneheim UH, Isaksson U, Persson Ljung I-M, Jansson L. Balancing between contradictions. The meaning of interaction with people suffering from dementia and ‘behavioural disturbances’. Int J Aging Hum Dev. In press.
26. Graneheim UH, Norberg A, Jansson L. Interaction relating to privacy, identity, autonomy and security. An observational study focusing on a woman with dementia and ‘behavioural disturbances’ and on her care providers. J Adv Nurs 2001; 36:256-265.
27. Hallberg IR, Norberg A. Staff’s interpretation of the experience behind vocally disruptive behaviour in severely demented patients and their feelings about it. An explorative study. Int J Aging Hum Develop 1990; 31:295-305.
28. Desai AK, Grossberg GT. Recognition and management of behavioural disturbances in dementia. J Clin Psychiatry 2001; 3:93-109.
29. Lawton MP. Environment and Aging. Albany: Center for the Study of Aging 1986.
30. Carp FM. Assessing the environment. Ann Rev Gerontol Geriatr 1994; 14:302-314.
31. Diaz Moore K. Dissonance in the dining room: a study of social interaction in a special care unit. Qual Health Res 1999; 9:133-155.
32. McAllister CL, Silverman MA. Community formation and community roles among persons with Alzheimer’s disease: a comparative study of experiences in a residential Alzheimer’s facility and a traditional nursing home. Qual Health Res 1999; 9:65-85.
33. Morgan DG, Stewart NJ. The physical environment of special care units: needs of residents with dementia from the perspective of staff and family caregivers. Qual Health Res 1999; 9:105-119.
34. Zeisel J, Silverstein N, Hyde J, et al. Environmental correlates to behavioral health outcomes in Alzheimer’s special care units. Gerontologist 2003; 43:697-711.
35. Bråne G, Karlsson I, Kihlgren M, Norberg A. Integritypromoting care of demented nursing home patients: psychological and biochemical changes. Int J Geriatr Psychol 1989; 4:165-172.
36. Götestam KG, Melin L. Improving well-being for patients with senile dementia by minor changes in the ward environment. In: Levi L, ed. Society, Stress and Disease. Oxford: Oxford University Press 1987, 295-297.
37. Cohen-Mansfield J, Werner P. The effects of an enhanced environment on nursing home residents who pace. Gerontologist 2000; 38:199-208.
38. Mooney P, Nicell PL. The importance of exterior environment for Alzheimer residents: effective care and risk management. Healthcare Mgmnt Forum 1992; 5:23-29.
39. Day K, Carreon D, Stump C. The therapeutic design of environments for people with dementia: a review of the empirical research. Gerontologist 2000; 40:397-416.
40. Sloane PD, Mitchell CM, Weisman G, et al. The therapeutic environment screening survey for nursing homes (TESSNH): an observational instrument for assessing the physical environment of institutional settings for persons with dementia. J Gerontol Social Sci 2002; 57B:69-78.
41. Grant LA. Conceptualizing and measuring social and physical environments in special care units. Alzheimer Dis Assoc Disord 1994; 8:321-327.
42. Werezak LJ, Morgan DG. Creating a therapeutic psychosocial environment in dementia care. A preliminary framework. J Gerontol Nursing 2003; 29:18-25.
43. Norberg A. Interaction with people suffering severe dementia. In: Wimo A, Jönsson B, Karlsson G, Winblad B, eds. Health Economics of Dementia. Chichester: Wiley, 1998 113-121.
44. Edvardsson D. Atmosphere in care settings - towards a broader understanding of the phenomeno. Umeå University Medical Dissertations, New Series No 941, Umeå, Sweden 2005.
45. Edvardsson D, Sandman PO, Rasmussen B. Sensing an atmosphere of ease - a tentative theory of supportive ward environments. Scand J Caring Sci in press.
46. Edvardsson D, Sandman PO, Rasmussen B. Meanings of being in the physical environment of an oncology clinic. J Adv Nursing in press.
47. Whitehead A, Perdomo C, Pratt RD, et al. Donepezil for the symptomatic treatment of patients with mild to moderate Alzheimer’s disease: a meta-analysis of individual patient data from randomised controlled trials. Int J Geriatr Psychiatry 2004; 19:624-633.
48. Ritchie CW, Ames D, Clayton T, Lai R. Metaanalysis of randomized trials of the efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer disease. Am J Geriatr Psychiatry 2004; 289:358-369.
49. Trinh NH, Hoblyn J, Mohanty S, Yaffe K. Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis. JAMA 2003; 289:210-216.
50. Feldman H, Gauthier S, Hecker J, et al. A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer’s disease (published erratum appears in Neurology 2001; 57:2153). Neurology 2001; 57:613-620.
51. Feldman H, Gauthier S, Hecker J, et al. Efficacy and safety of donepezil in patients with more severe Alzheimer’s disease: a subgroup analysis from a randomized, placebocontrolled trial. Int J Geriatr Psychiatry 2005; 20:559-569.
52. Reisberg B, Doody R, Stoffler A, et al. Memantine in moderate to severe Alzheimer’s disease. N Engl J Med 2003; 348:1333-1341.
53. Tariot PN, Farlow MR, Grossberg GT, et al. Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial. JAMA 2004; 291:317-324.
54. Winblad B, Poritis N. Memantine in severe dementia: results of the 9M-Best Study (Benefit and efficacy in severely demented patients during treatment with memantine). Int J Geriatr Psychiatry 1999; 14:135-146.
55. Graneheim UH, Lundman B. Qualitative content analysis in nursing research: concepts, procedures and measures to achieve trustworthiness. Nurse Ed Today 2004; 24:105-112.